Chemicals

Savillex completes acquisition of Entegris life sciences fluid management business

The deal adds Aramus and PE bags, single-use assemblies and related components to Savillex’s high-purity fluid-handling portfolio.

Luciana FerreiraOctober 21, 20265 min read5 views
Single-use bioprocessing bags, tubing and connectors arranged in a clean laboratory setting, illustrating the fluid-handling portfolio added by the acquisition.

Savillex, LLC has completed its acquisition of the Life Sciences Fluid Management business of Entegris, Inc., the company announced. Savillex, based in Eden Prairie, Minnesota, supplies high-purity fluid handling solutions for life science and laboratory applications. Entegris is based in Billerica, Massachusetts. The purchase price and other financial terms were not disclosed.

The acquired business brings a portfolio used in bioprocessing and pharmaceutical manufacturing. It includes Aramus bags and PE bags, single-use assemblies and components employed in discovery, clinical and commercial manufacturing. Savillex said the addition broadens its life sciences range with more high-performance single-use solutions.

Portfolio and team

Along with the products, Savillex gains the Life Sciences Fluid Management team and its technologies in high-purity fluid management. The company said customers can expect more single-use options, additional technical expertise and expanded capabilities for applications that run from early-stage research through commercial production. Savillex also said the combined strengths should help customers manage increasingly complex bioprocessing workflows.

Eric Giesing, chief executive officer of Savillex, said the acquired business has established a reputation in high-purity single-use bioprocessing and that the Aramus line fits alongside its Savillex, Containment and Bioprocessing product lines. He said the transaction expands the company’s portfolio and allows it to offer a wider range of solutions to biopharmaceutical and pharmaceutical customers. Giesing also welcomed the team and said Savillex will continue investing in technologies intended to help customers speed development and production of critical therapies.

Chris Bedi, general manager of Fluid Management at Savillex, said the acquisition offers an opportunity to bring a broader set of high-value fluid management solutions to pharmaceutical and biopharmaceutical customers worldwide. He said the Fluid Management portfolio complements Savillex’s existing capabilities and that the combined organization will continue to provide innovative solutions while expanding support for partners across drug development. Bedi said the company is eager to help customers bring new medicines to patients.

Strategic fit

Savillex described the deal as a step in its strategy to provide industry-leading solutions for the life sciences market. The company said it remains committed to innovation, quality and customer partnership as it expands its portfolio to meet changing needs among biopharmaceutical and pharmaceutical manufacturers. Terms of the transaction were not disclosed.

EC M&A, based in New York, served as financial advisor to Savillex, and Sidley Austin LLP, based in Chicago, served as legal counsel.